Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward

Infection Control and Hospital Epidemiology

Volumn 24, Issue 9, 2003, Pages 673-678

  Herr, Caroline Eva Wella ^a   Heckrodt, Thomas Hilarius ^a   Hofmann, Frank Andreas ^a   Schnettler, Reinhard ^a   Eikmann, Thomas Friedrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FOSFOMYCIN; PSEUDOMONIC ACID; VANCOMYCIN;

ADULT; AGED; ANTISEPSIS; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CARRIER; BED; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; COST MINIMIZATION ANALYSIS; DISINFECTION; DRUG COST; ERADICATION THERAPY; FEMALE; HEALTH CARE COST; HEALTH PROMOTION; HOSPITAL EQUIPMENT; HOSPITAL INFECTION; HUMAN; HYGIENE; INFECTION CONTROL; LENGTH OF STAY; MALE; MEDICAL RECORD; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PROTECTIVE CLOTHING; RETROSPECTIVE STUDY; SKIN CARE; SOCIAL SECURITY; SURGICAL WARD; UNIVERSITY HOSPITAL;

AGED; COST CONTROL; COSTS AND COST ANALYSIS; FEMALE; HOSPITAL COSTS; HUMANS; INFECTION CONTROL; MALE; MEDICAL AUDIT; METHICILLIN RESISTANCE; MIDDLE AGED; PATIENT ISOLATION; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURGERY DEPARTMENT, HOSPITAL;

EID: 0141645534     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502274     Document Type: Article

References (16)

1. Farr BM, Jarvis WR. Would active surveillance cultures help control healthcare-related methicillin-resistant Staphylococcus aureus infections? Infect Control Hosp Epidemiol 2002;23:65-68.
2. Geldner G, Ruoff M, Hoffmann HJ, Kiefer P, Georgieff M, Wiedeck H. Cost analysis concerning MRSA-infection in ICU [in German]. Anasthesiol Intensivmed Notfallmed Schmerzther 1999;34:409-413.
3. Rubin PJ, Harrington CA, Poon A, Dietrich K, Greene JA, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999;5:9-17.
4. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99-104.
5. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473-477.
6. Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745-1751.
7. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002;51:126-132.
8. Empfehlung zur Prävention und Kontrolle von Methicillin-resistent Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am RKI. Bundesgesundheitsbl 1999;42:954-958.
9. Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals: Part II. Recommendations for isolation precautions in hospitals. Am J Infect Control 1996;24:32-52.
10. Gesetz zur Verhütung und Bekämpfung von Infektionskrankheiten beim Menschen Infektionsschutzgesetz: IFSG. Bundesgesetzblatt Jahrgang 2000;33.
11. Domann E, Hossain H, Fussle R, Chakraborty T. Rapid and reliable detection of multiresistant Staphylococcus aureus (MRSA) by multiplex PCR [in German]. Dtsch Med Wochenschr 2000;125:613-618.
12. Vandenbroucke-Grauls CM. Methicillin-resistant Staphylococcus aureus control in hospitals: the Dutch experience. Infect Control Hosp Epidemiol 1996;17:512-513.
13. Minnesota Department of Health, Infectious Disease Prevention and Control Division, Facility and Provider Compliance Division. Guideline for the Management of Antimicrobial Resistant Microorganisms in Minnesota Long-Term Care Facilities. St. Paul, MN: Minnesota Department of Health; 2000. Available at www.health.state.mn.us/ divs/dpc/ades/infect/guideline.htm. Accessed August 10, 2003.
14. Rubinovitch B, Pittet DI. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned? J Hosp Infect 2001;47:9-18.
15. Kluytmans J, van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: Epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997;10:505-520.
16. Andersen BM, Lindemann R, Bergh K, et al. Spread of methicillin-resistant Staphylococcus aureus in a neonatal intensive unit associated with understaffing, overcrowding and mixing of patients. J Hosp Infect 2002;50:18-24.